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INTRODUCTION
Primary cardiac angiosarcoma is a rare, but life - threatening
entity because it has aggressive characteristics and the prognosis
after a diagnosis made is very poor. Patients who suffered from
cardiac angiosarcome usually do not complaint about any symp-
toms unless the disease is advanced. Therefore, most cases are
diagnosed incidentally or too late, subsequently resulting in the
poor outcomes (1). Eighty percent of cardiac angiosarcoma pre-
sent with metastasis with median survival of only six months
(2, 3). Herein, we describe a case of primary cardiac angiosarcoma
with a better survival following surgical resection and radioche-
motherapy.
CASE REPORT
A healthy 18-year-old girl was referred to our hospital for further
evaluations of cardiac angiosarcoma, which was diagnosed by a
femoral transvenous biopsy. On admission, transthoracic echo-
cardiography showed an immobile 4.6 cm3.7 cm cardiac mass
possibly originating from the right atrial appendage and no peri-
cardial effusion. The mass was occupying right atrial chamber and
partially, invading into annulus of tricuspid valve without tricuspid
valve regurgitation on transesophageal echocardiography (Figure
1 A). Computed tomography showed that the mass was in the right
atrial chamber and it was near the ascending aorta without evi-
dence of invasion (Figure 1 B and C). Further evaluations including
lung perfusion scan and magnetic resonance imaging demon-
strated no evidence of metastasis. Cardiac catherization confirmed
two feeding arteries from right coronary artery into the mass. At
surgery, after pericardiotomy, the mass was seen to be protruding
from right atrial appendage and adhering to right side of pericar-
dium (Figure 2 A). After establishment of cardiopulmonary by-
pass and cardiac arrest achieved, resection of the entire mass with
right atrial appendage and partially free wall of right atrium was
performed (Figure 2 B). We could identify the feeding arteries and
ligated them. Cryoablation was used for edge of right atrium resec-
tion and we reconstructed it with bovine pericardial patch. Intraop-
erative pathological evaluation of some suspicions lesions revealed
finding of invasion into superior vena cava and annulus of tricuspid
valve. However, because of difficulty of radical resection with more
invasiveness, surgery was over. The histological findings were
consistent with cardiac angiosarcoma (Figure 3) and immunologi-
cal staining was positive for CD34 and CD31 (Figure 4 A and B).
She was discharged on postoperative day 13. Afterward, although
she received radiochemotherapy, she died of liver metastasis of
cardiac angiosarcoma more than three years after surgical resec-
tion of primary cardiac angiosarcoma. Local recurrence of cardiac
angiosarcoma was absent.
DUSCUSSION
Primary cardiac sarcomas are neoplasms deriving from mesen-
chymal cells and limited to the heart at the time of diagnosis. The
prevalence of primary cardiac sarcomas at autopsy was 0.0017%,
with an incidence from 0.001% to 0.03%. Sarcomas account for ap-
proximately 10% to 20% of total primary cardiac tumors (4). Metas-
tatic tumors to the heart are more frequently than primary cardiac
tumors.
In adults, especially in males with a mean age of 50 years (5),
primary cardiac angiosarcoma is the most common type of cardiac
sarcoma. Approximately seventy- five percent of primary cardiac
angiosarcoma occurs in the right side of the heart, in particular
right atrium.
A diagnosis of primary cardiac angiosarcoma tends to be delayed
because of the absence of clinical signs or symptoms for a long time
(1). Symptoms are based on the cardiac location of the tumor, its
size, the degree of myocardial involvement and the presence of
metastasis (5). Given the propensity of primary angiosarcoma in-
volving the right-sided heart, patients may present right-sided
heart failure, superior vena cava obstruction, pericardial effusion
(6).
Because of highly aggressive and invasive propensity of cardiac
angiosarcoma, pericardial constriction and cardiac tamponade are
frequent, and lung, bone, liver and spleen metastasis is reported.
Unfortunately, 66% to 89% of patients have evidence of metastasis
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at the time of diagnosis (6). In this situation, the prognosis is very
poor with median survival of six months (2).
We applied immunostaining for CD31 and CD34 to diagnose
angiosarcoma. CD31 and CD34 are useful markers for normal
endothelial cells. Therefore, use of these antibodies leads to a defi-
nite diagnosis of angiosarcoma (7).
Surgery remains the mainstay of treatment in the absence of any
extensive local spread and metastases. Liombart-Cussac et al. re-
ported that only a surgical radical resection was found to be sig-
nificantly associated with longer survival. They also found that
adjuvant chemotherapy postoperatively failed to modify the natural
course of this disease (8). Primary tumor resection can contribute
to improve median survival (3).
Patients with primary cardiac angiosarcoma had a shorter me-
dian survival of seven months and median disease- free progres-
sion interval of four months compared to other histological types
(8). In present case, radiochemotherapy after surgical resection was
effective because it inhibited aggressiveness of the angiosarcoma.
We understand that radical treatment for primary angiosarcoma
is difficult. Also, cardiac transplant for patients with these kinds of
disease is not an option in Japan. Surgical resection and radioche-
motherapy, which may be ineffective in some cases are main stay
to deal with highly aggressive angiosarcoma. Surgical resection com-
bined with radiochemotherapy was so effective to achieve relatively
Figure 1 A. Transesophageal echocardiography shows that a mass is occupying the right atrial chamber and partially, invading into annulus of
tricuspid valve.
B. The axial view of enhanced computed tomography shows a mass is in the right atrial chamber (askerisk).
C. The coronal view of enhanced computed tomography shows a mass is near the ascending aorta with no evidence of invasion (askerisk).
Figure 2 A. A mass is seen to be protruding from right atrial appendage and adhering to right side of pericardium.
B. Resection of the entire mass with right atrial appendage and partially free wall of right atrium is performed.
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better survival.
CONFLICTS OF INTEREST DISCLOSURE
The authors have no financial or institutional interest in this
study.
REFERENCES
1. Bellitti R, Buonocore M, De Rosa N, Covino FE, Casale B,
Sabte P : Primary cardiac angiosarcoma in a 25-year-old man :
excision adjuvant chemotherapy, and multikinase inhibitor
therapy. Tex Heart Inst J 40 : 186-188, 2013
2. Prabu MPR, Thulkar S, Ray R, Bakhshi S : Primary cardiac
angiosarcomea with good response to paclitaxel. J Thorac
Oncol 10 : 1778-1779, 2011
3. Look Hong NJ, Pandalai PK, Hornick JL, Shekar PS, Harmon
DC, Chen YL, Bustrynski JE, Baldini EH, Raut CP : Cardiac
angiosarcoma management and outcomes : 20-year single-
institution experience. Ann Surg Oncol 19 : 2707-2715, 2012
4. Orlandi A, Ferlosio A, Roselli M, Chiariello L, Spagnoli LG :
Cardiac sarcomas : an update. J Thorac Oncol 5 : 1483-9, 2010
5. Herrmann MA, Shankerman RA, Edwards WD, Shub C, Schaff
HV : Primary cardiac angiosarcoma : a clinicopathologic study
of six cases. J Thorac Cardiovasc Surg 103 : 655-64, 1992
6. Bouma W, Lexis CPH, Willems T, Suurmeijer AJH, van der
Horst ICC, Ebels T, Mariani MA : Successful surgical excision
of primary right atrial angiosarcoma. J Cardiothorac Surg
6 : 47, 2011
7. Furihata M, Takeuchi T, Iwata J, SOnobe H, Ohtsuki Y,
Wakatsuki A, Morioka N, Sagara Y : Primary ovarina angio-
sarcoma : a case report and literature review. Pathology In-
ternational 48 : 967-973, 1998
8. Liombart-Cussac A, Pivot X, Contesso G, Rhor-Alvarado A,
Delord JP, Spielmann M, Tursz T, Le Cesne A : Adjuvant che-
motherapy for primary cardiac sarcomas : the IGR experi-
ence. Br J Cancer 78 : 1624-8, 1998
Figure 3 The histological findings are consistent with cardiac angiosarcoma. The tumor shows atypical spindle or endothelial cells which are
lined around the vasoformative structures. Within those structures, erythrocytes can be recognized.
Figure 4 Immunochemical staining for CD31 (A) and CD34 (B) shows the focal endothelial differentiation. The positive for these immunochemical
staining is brownish.
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